(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 8.54% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Mckesson's revenue in 2025 is $377,595,000,000.On average, 19 Wall Street analysts forecast MCK's revenue for 2026 to be $51,353,589,262,766, with the lowest MCK revenue forecast at $49,294,530,021,044, and the highest MCK revenue forecast at $53,758,934,654,600. On average, 17 Wall Street analysts forecast MCK's revenue for 2027 to be $55,573,205,410,898, with the lowest MCK revenue forecast at $52,121,414,120,755, and the highest MCK revenue forecast at $59,282,845,547,730.
In 2028, MCK is forecast to generate $60,113,608,908,577 in revenue, with the lowest revenue forecast at $55,168,831,749,255 and the highest revenue forecast at $65,506,418,651,485.